Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Adjuvant Chemotherapy with Ro09-1978 plus L-OHP in Resected Stage II–III Gastric Cancer
jRCT2080221830Phase 2
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Jun 2012
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tegafur and oxaliplatin in gastric adenocarcinoma, sponsored by Chugai Pharmaceutical Co., Ltd.
02
Drugs
tegafuroxaliplatin
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on jRCT2080221830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221830.